COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 176 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,677 | +15.0% | 970 | +10.6% | 0.00% | – |
Q2 2023 | $18,843 | -91.9% | 877 | -91.0% | 0.00% | – |
Q1 2023 | $233,805 | +64.7% | 9,751 | +59.9% | 0.00% | – |
Q4 2022 | $142,000 | +52.7% | 6,099 | +4.3% | 0.00% | – |
Q3 2022 | $93,000 | +564.3% | 5,846 | +620.8% | 0.00% | – |
Q2 2022 | $14,000 | -12.5% | 811 | 0.0% | 0.00% | – |
Q1 2022 | $16,000 | +33.3% | 811 | +17.4% | 0.00% | – |
Q4 2021 | $12,000 | -40.0% | 691 | -33.5% | 0.00% | – |
Q3 2021 | $20,000 | -25.9% | 1,039 | -9.6% | 0.00% | – |
Q2 2021 | $27,000 | +8.0% | 1,149 | +7.2% | 0.00% | – |
Q1 2021 | $25,000 | -16.7% | 1,072 | -30.4% | 0.00% | – |
Q4 2020 | $30,000 | +30.4% | 1,541 | +35.3% | 0.00% | – |
Q3 2020 | $23,000 | -8.0% | 1,139 | -18.4% | 0.00% | – |
Q2 2020 | $25,000 | +127.3% | 1,395 | +104.5% | 0.00% | – |
Q1 2020 | $11,000 | – | 682 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |